Market cap
$9.228 B
$44.78 +3.35%
Close of 21 Sept 2026
Revenue
$2.09B
#1117 by revenue
Earnings
$424.9M
#685 by earnings
Shares outstanding
216,920,735
Latest filing cover page
P/E ratio
21.7
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 160 →What if Qiagen were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Qiagen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.